- A Common Chk1-Dependent Phenotype of DNA Double-Strand Break Suppression in Two Distinct Radioresistant Cancer TypesDinkelborg P. H.; Wang M.; Gheorghiu L.; Hong T. S.; Jimenez R. B.; Grossmann P.; Dejan J.; Gurski J. M.; Benes C.; Borgmann K.; Willers H.60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 2018-10-21 To 2018-10-24.
- The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistanceJiang Weiliang; Zhao Senlin; Shen Jia; Guo Lihong; Sun Yi; Zhu Yuntian; Ma Zhixiong; Zhang Xin; Hu Yangyang; Xiao Wenqin; Li Kai; Li Sisi; Zhou Li; Huang Li; Lu Zhanjun; Feng Yun; Xiao Junhua; Zhang Eric Erquan; Yang Lijuan; Wan RongCELL DEATH & DISEASE, 2018, 9: 149.
- Defective Cell Cycle Checkpoints as Targets for Anti-Cancer TherapiesBrian Gabrielli; Kelly Brooks; Sandra PaveyFrontiers in Pharmacology, 2012, 3.
期刊论文
Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells
23阅读
